Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Part B Reimbursement Covered By U.S.-Australia Trade Pact

This article was originally published in The Pink Sheet Daily

Executive Summary

Medicare Part D and Medicaid are excluded from Free Trade Agreement drug provisions, as are VA and DoD drug purchases, U.S. Trade Representative says. FTA does not prevent Congress from passing drug importation legislation.

You may also be interested in...



U.S. Trade Agreement Talks On Drug Pricing Shift To G-8 Nations

Administration’s focus "is primarily on the G-8 countries" following a bilateral agreement with Australia that increases transparency in drug reimbursement determinations, U.S. Trade Rep. Zoellick tells Senate Finance Committee.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Deal Watch: Sanofi, Boehringer Swap Side Businesses

Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.

Topics

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel